Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Abdullah Atyah Ali, Ass.Lecture General Surgery
Qena Oncology Center--Luxor University
Study Director - Abobakr Mohammed, Resident General Surgery
Qena Oncology Center--Qena General Hospital
Study Chair - Ali Hassan, Resident General Surgery
Qena Oncology Center --Qena University
Study Chair - Amr M Makky, Specialist Surgical Oncology
Qena Oncology Center- Medical Military Academy
Study Director - Hussein El Lithy, Resident General Surgery
Qena Oncology Center--Qena General Hospital
Study Chair - Mahmoud Rabeea Ahmed, Resident General Surgery
Qena Oncology Center-Aswan University
Study Chair - Mena Zarief Malaty, Resident General Surgery
Qena Oncology Center--Nag hammady Hospital
Study Chair - Mina Romany Tawfeek, Specialist General Surgery
Qena Oncology Center
Study Director - Mohamed Abouelmagd Salem, Prof. Surgical Oncology
Qena Oncology Center-ٍSouth Egypt Center Institute Assiut University
Study Chair - Mohamed Ahmed Orabi, Specialist Surgical Oncology
Qena Oncology Center
Principal Investigator - Mohamed H Mahran, Ass.Prof. Surgical Oncology
Qena Oncology Center-ٍSouth Egypt Center Institute Assiut University
Study Chair - Mohamed Hasan Abdel-Aal, Director of QOC
Qena Oncology Center
Study Chair - Mohamed Mahmoud El Zeer, Resident General Surgery
Qena Oncology Center- Sohag University
Study Chair - Mohamed Saeed Ayaty, Ass.Prof. Surgical Oncology
Qena Oncology Center-National Cancer Institute Cairo University
Study Chair - Mohamed Taha Mousa, Resident Surgical Oncology
Qena Oncology Center
Study Director - Mostafa Sayedd Abd el Rahaman, Resident Surgical Oncology
Qena Oncology Center
Study Chair - Remon Elia Lukas, Specialist Surgical Oncology
Qena Oncology Center
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jun 2022
- Primary completion
- 31 May 2023
- Completion
- 31 May 2023
- Last update posted
- 24 May 2022
- Registered enrollment
- 40
- Registry id
- NCT05367869
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.